Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.
Saved in:
| Title: | Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective. |
|---|---|
| Authors: | Scholte M; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands. mirre.scholte@mumc.nl.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands. mirre.scholte@mumc.nl., Ramaekers B; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands., Danopoulos E; Kleijnen Systematic Reviews (KSR) Ltd, York, UK.; Statistical Laboratory, Department of Pure Mathematics and Mathematical Statistics, University of Cambridge, Cambridge, UK., Grimm SE; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands., Fernandez Coves A; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands., Tian X; Kleijnen Systematic Reviews (KSR) Ltd, York, UK., Debray T; Smart Data Analysis and Statistics B.V., Utrecht, The Netherlands., Chen J; Kleijnen Systematic Reviews (KSR) Ltd, York, UK., Stirk L; Kleijnen Systematic Reviews (KSR) Ltd, York, UK., Croft R; Kleijnen Systematic Reviews (KSR) Ltd, York, UK., Joore M; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands., Armstrong N; Kleijnen Systematic Reviews (KSR) Ltd, York, UK. |
| Source: | PharmacoEconomics [Pharmacoeconomics] 2024 Aug; Vol. 42 (8), pp. 829-832. Date of Electronic Publication: 2024 May 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-2027 |
|---|---|
| DOI: | 10.1007/s40273-024-01394-8 |
